Analyst Ratings for Sarepta Therapeutic (SRPT)
SRPT Rating Summary
SRPT Price Target Summary
- Highest: $63.00 (Baird)
- Lowest: $9.00 (WBB Securities)
- Average: $44.38
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$44.38 (+17.4%)
Avg. $ Target:
$44.38 (+17.4%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/22/2013 | Needham & Company | New Coverage | Buy (N/A) |
57.00 (N/A) |
32.86 | 37.82 | 15.09% | Details |
| 4/16/2013 | Leerink Swann | Downgrade | Market Perform (Outperform) |
41.00 (45.00) |
39.24 | 37.82 | -3.62% | Details |
| 4/16/2013 | Janney Montgomery Scott | Downgrade | Neutral (Buy) |
34.00 (34.00) |
39.24 | 37.82 | -3.62% | Details |
| 4/9/2013 | Canaccord Genuity | New Coverage | Buy (N/A) |
47.00 (N/A) |
35.85 | 37.82 | 5.5% | Details |
| 4/4/2013 | Baird | New Coverage | Outperform (N/A) |
63.00 (N/A) |
34.05 | 37.82 | 11.07% | Details |
| 3/19/2013 | Deutsche Bank » Updated 4/9/2013 |
New Coverage | Buy (N/A) |
45.00 (N/A) |
33.03 | 37.82 | 14.5% | Details |
| 1/25/2013 | Cowen | New Coverage | Outperform (N/A) |
N/A (N/A) |
24.39 | 37.82 | 55.06% | Details |
| 11/27/2012 | Dawson James | New Coverage | Market Outperform (N/A) |
N/A (N/A) |
31.01 | 37.82 | 21.96% | Details |
| 11/26/2012 | Burrill » Updated 5/13/2013 |
New Coverage | Market Outperform (N/A) |
39.00 (N/A) |
29.35 | 37.82 | 28.86% | Details |
| 9/12/2012 | WBB Securities | Downgrade | Sell (Hold) |
9.00 (8.00) |
13.61 | 37.82 | 177.88% | Details |
| 8/27/2012 | ThinkEquity » Updated 10/4/2012 |
New Coverage | Buy (N/A) |
40.00 (15.00) |
10.78 | 37.82 | 250.83% | Details |
